Bedford Group Transearch Life Sciences Congratulates Apotex on the appointment of former BIOTECanada CEO as new Vice President, Government Relations & Policy

Bedford Group Transearch Life Sciences congratulates Andrew Casey on his appointment as the new Vice President, Government Relations & Policy with Apotex Canada. Casey most recently spent the last 12+ years as the President & CEO for BIOTECanada, with prior posts as Vice President, International Trade and Public Affairs with Forest Products Association of Canada. He started his career as a Legislative Assistant & Press Secretary in the House of Commons with The Government of Canada and is a graduate from Carleton University with a Bachelor of Arts (Political Science & History).

About Apotex

Apotex’s purpose is to improve everyday access to affordable, innovative medicines and health products for patients and consumers worldwide. With Canadian roots and a broad portfolio of generic, biosimilar, and innovative branded products, Apotex is the largest Canadian-based pharmaceutical company and a health partner of choice for the Americas for pharmaceutical licensing and product acquisitions. The company’s unwavering dedication to its purpose and the healthcare community has established Apotex as a trusted partner to healthcare professionals and patients around the world.